Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1980 Jul;18(1):69–76. doi: 10.1128/aac.18.1.69

Biliary elimination of mezlocillin: an experimental and clinical study.

J M Brogard, J Kopferschmitt, J P Arnaud, M Dorner, J La Villaureix
PMCID: PMC283941  PMID: 6448023

Abstract

The biliary elimination of mezlocillin, a new semisynthetic penicillin of the acyl-ureido-penicillin group, was investigated in vitro in rabbit liver preparations and in vivo in humans. Experimentally, mezlocillin recovery in the bile during perfusion of isolted rabbit liver (3 h; n = 5) averaged 20.3% of the administrered dose (10 mg). The mean peak concentration in the bile (758 +/- 129.3 micrograms/ml) was reached between 0.5 and 1 h. Biliary clearance was 169 ml/h. In healthy subjects (n = 5), the concentrations of antibiotic measured in the duodenal fluid during a period of 4 h after intravenous administration of 5 g of mezlocillin ranged between 440 and 637 micrograms/ml. In 10 cholecystectomized patients provided with a T-tube, intramuscular injection of 1 g of mezlocillin resulted in a biliary peak concentration of 295.7 +/- 58.1 micrograms/ml. Mean total amount of antibiotic eliminated in the bile over 12 h corresponded to 2.6% of the administered dose. Assays performed during surgery after intravenous administration of 2 g of mezlocillin (n = 10) showed antibiotic activity of 895 +/- 196 micrograms/ml in the common duct bile and 402 +/- 133 micrograms/ml in the gallbladder bile. These data were compared with the values determined for 11 other beta-lactamines studied under identical conditions.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bodey G. P., Pan T. Mezlocillin: in vitro studies of a new broad-spectrum penicillin. Antimicrob Agents Chemother. 1977 Jan;11(1):74–79. doi: 10.1128/aac.11.1.74. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brogard J. M., Kuntzmann F., Dorner M., Haegele P., Lavillaureix J. Etude expérimentale et pharmacologie humaine de l'élimination biliaire d'une céphalosporine, la céphalexine. Application thérapeutique. Pathol Biol (Paris) 1971 Dec;19(23):1121–1131. [PubMed] [Google Scholar]
  3. Brogard J. M., Pinget M., Meyer C., Dorner M., Lavillaureix J. Biliary excretion of ampicillin: experimental and clinical study. Chemotherapy. 1977;23(4):213–226. doi: 10.1159/000221989. [DOI] [PubMed] [Google Scholar]
  4. RUNDLE F. F., CASS M. H., ROBSON B., MIDDLETON M. Bile drainage after choledochostomy in man, with some observations on biliary fistula. Surgery. 1955 Jun;37(6):903–910. [PubMed] [Google Scholar]
  5. Schacht P. Neue Entwicklungen und theoretische Grundlagen bei Penizillinen. Med Welt. 1978 Apr 28;29(17):696–705. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES